Tonghua Golden-horse Pharmaceutical Industry Co Ltd
000766
Company Profile
Business description
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Contact
No. 999, Jinma Road
Erdaojiang District
TonghuaJilin134001
CHNT: +86 4353246712
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,532
Stocks News & Analysis
stocks
PayPal earnings: Growth slows, new CEO appointed
We expect to lower our fair value estimate of PayPal stock.
stocks
Morningstar initiates on ASX income play
This REIT may be an option for investors seeking income.
stocks
What Goodman’s upcoming earnings could reveal about data centre & AI growth
Answering key questions about Goodman & its data centre pipeline ahead of earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,210.30 | 62.20 | 0.68% |
| CAC 40 | 8,179.50 | 1.67 | -0.02% |
| DAX 40 | 24,780.79 | 16.73 | -0.07% |
| Dow JONES (US) | 49,197.49 | 210.17 | -0.43% |
| FTSE 100 | 10,314.59 | 26.97 | -0.26% |
| HKSE | 26,724.94 | 109.83 | -0.41% |
| NASDAQ | 23,255.19 | 336.92 | -1.43% |
| Nikkei 225 | 54,321.03 | 399.63 | -0.73% |
| NZX 50 Index | 13,467.29 | 54.85 | 0.41% |
| S&P 500 | 6,904.93 | 71.51 | -1.03% |
| S&P/ASX 200 | 8,935.50 | 83.20 | 0.94% |
| SSE Composite Index | 4,067.67 | 0.07 | -0.00% |